Riskpilot← Back to searchSign inGet full accessHemo Aktiebolag
ABActiveOrg 5563896355Retail sale of clothing · NACE 4771Est. 19900 employees
Revenue 2025
SEK 0
EBITDA margin
—
-91% vs 2024
Equity ratio
98.5%
Financial strength
Net profit 2025
SEK 38K
-18% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -12K | -91% |
| Net profit | SEK 38K | -18% |
| Total assets | SEK 1,9M | -8% |
| Equity | SEK 1,8M | -9% |
| Employees | 0 | — |
Legal name
Hemo Aktiebolag
Org number
5563896355
Legal form
Aktiebolag
NACE code
4771 · Retail sale of clothing
Founded
5 april 1990
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva försäljning av textilvaror på torg och marknader och därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | −0 | — | — | — |
| EBITDA | −62 | −9 | −6 | −6 | −12 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −62 | −9 | −6 | −6 | −12 |
| Net financials | 4 | 5 | 65 | 64 | 60 |
| Profit before tax | −58 | −4 | 59 | 57 | 47 |
| Tax | −0 | — | — | −11 | −10 |
| Net profit | −58 | −4 | 59 | 46 | 38 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 479 | 2 290 | 2 154 | 2 012 | 1 857 |
| Equity | 2 479 | 2 290 | 2 154 | 2 000 | 1 829 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 0 | — | — | 11 | 28 |
| Total debt | — | — | — | 11 | 28 |
EBITDA margin
-1232500.0%
This company
15.8%
Market median
-7800733% vs market
20212025
Equity ratio
98.5%
This company
38.2%
Market median
+158% vs market
20212025
Return on equity
2.1%
This company
18.4%
Market median
-89% vs market
20212025
Net profit margin
3757300.0%
This company
8.1%
Market median
+46386320% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
JO Chief Auditor | Chief Auditor | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hemo Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Oscar Larsson | Chief Auditor | 0 companies |
| Magnus Mathias Millberg | Deputy Board Member | 0 companies |
| Hans Magnus Millberg | Board of Directors | 0 companies |